Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

2021853 citationsJournal Articlegreen Open Access

Authors

Hiam Chemaitelly · Weill Cornell Medical College in Qatar

Patrick Tang · Weill Cornell Medical College in Qatar

Mohammad R. Hasan · Weill Cornell Medical College in Qatar

Sawsan AlMukdad · Weill Cornell Medical College in Qatar

Hadi M. Yassine · Weill Cornell Medical College in Qatar

Fatiha M. Benslimane · Weill Cornell Medical College in Qatar

Hebah A. Al Khatib · Weill Cornell Medical College in Qatar

Abstract

BNT162b2-induced protection against SARS-CoV-2 infection appeared to wane rapidly following its peak after the second dose, but protection against hospitalization and death persisted at a robust level for 6 months after the second dose. (Funded by Weill Cornell Medicine-Qatar and others.).

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Immune responses and vaccinations Diverse Scientific Research Studies

Publication Details

Published in: New England Journal of Medicine

Volume 385, Issue 24, pp. e83-e83

DOI: 10.1056/nejmoa2114114

Field-Weighted Citation Impact: 51.63

Command Palette

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Authors

Abstract

Topics & Keywords

Publication Details